Home

Glaxosmithkline Pharmaceuticals Ltd PE Ratio

Image

Glaxosmithkline Pharmaceuticals Ltd

NSE: GLAXO

PE

43.9

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of Glaxosmithkline Pharmaceuticals Ltd is 43.9 as of 15 Jan 15:30 PM .
  • The P/E Ratio of Glaxosmithkline Pharmaceuticals Ltd changed from 226.4 on March 2020 to 55.8 on March 2024 . This represents a CAGR of -24.43% over 5 years.
  • The Latest Trading Price of Glaxosmithkline Pharmaceuticals Ltd is ₹ 2043 as of 15 Jan 16:01 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Glaxosmithkline Pharmaceuticals Ltd

No data available

Company Fundamentals for Glaxosmithkline Pharmaceuticals Ltd

Image

Glaxosmithkline Pharmaceuticals Ltd

NSE: GLAXO

Share Price

₹ 2043.35

-33.85 (-1.63%)

stock direction

Last updated on: Jan 15, 2025

Market Price of Glaxosmithkline Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Glaxosmithkline Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 20252077.2
13 Jan 20252090.2
10 Jan 20252190.05
09 Jan 20252208.75
08 Jan 20252207.85
07 Jan 20252230.1
06 Jan 20252203.2
03 Jan 20252240.85
02 Jan 20252221.4
01 Jan 20252234.2

SWOT Analysis Of Glaxosmithkline Pharmaceuticals Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Glaxosmithkline Pharmaceuticals Ltd

Asset Value vs Market Value of Glaxosmithkline Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Glaxosmithkline Pharmaceuticals Ltd35189
Sun Pharmaceuticals Industries Ltd424382
Divis Laboratories Ltd159224
Cipla Ltd116943
Dr Reddys Laboratories Ltd111588

PE Ratio of Glaxosmithkline Pharmaceuticals Ltd Explained

``

35189

Market cap

675

Earnings

43.9X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Glaxosmithkline Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in %

About Glaxosmithkline Pharmaceuticals Ltd

  • GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together.
  • The Company is headquartered in Mumbai and it has six branch offices, a manufacturing facility at Nashik in Maharashtra, 22 contract manufacturing organisations (CMOs) with regional and sales hubs across India.
  • The Company is engaged interalia, in the business of manufacturing, distributing and trading in pharmaceuticals. The Company's portfolio includes General Medicines, Vaccines and Specialty medicines that help prevent and treat disease.
  • Their prescription medicines range across therapeutic areas, such as Anti-Infectives, Dermatology, Gynaecology, Diabetes, Oncology, Cardiovascular Disease and Respiratory Diseases.

Glaxosmithkline Pharmaceuticals Ltd News Hub

Glaxosmithkline Pharmaceuticals consolidated net profit rises 37.87% in the June 2024 quarter

Net profit of Glaxosmithkline Pharmaceuticals rose 37.87% to Rs 182.33 crore in the quarter ended Ju

Read more

2024-08-05 00:00:00

GSK Pharma Q1 PAT climbs 39% YoY to Rs 182 crore

Revenue from operations grew by 9.89% year on year (YoY) to Rs 811 crore during the quarter ended Ju

Read more

2024-08-03 00:00:00

GlaxoSmithKline Pharmaceuticals to declare Quarterly Result

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 O

Read more

2024-10-25 00:00:00

Board of GlaxoSmithKline Pharmaceuticals recommends Special Interim Dividend

GlaxoSmithKline Pharmaceuticals announced that the Board of Directors of the Company at its meeting

Read more

2024-10-29 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Glaxosmithkline Pharmaceuticals Ltd

What is the current PE Ratio of Glaxosmithkline Pharmaceuticals Ltd?

The Current PE Ratio of Glaxosmithkline Pharmaceuticals Ltd is 43.89 as on 15 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 15 Jan 2025.

What was the PE Ratio of Glaxosmithkline Pharmaceuticals Ltd last year?

The PE Ratio of Glaxosmithkline Pharmaceuticals Ltd was 36.73 last year, now the PE ratio is 43.89, showing a year-on-year growth of 19.5%.

What does the PE Ratio of Glaxosmithkline Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Glaxosmithkline Pharmaceuticals Ltd is 43.89. This ratio indicates that investors are willing to pay 43.89 times the earnings per share for each share of Glaxosmithkline Pharmaceuticals Ltd.

What is the PE Ratio Growth of Glaxosmithkline Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Glaxosmithkline Pharmaceuticals Ltd grew by 19.5% whereas, the EPS ratio grew by 36.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions